- News & Analysis
- Home
- Latest News
- Reports
- Podcast
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Events
Page 366
PetaGene generates $2.1m
PetaGene hopes its data compression technology will aid the genomic sequencing industry.
Jan 9, 2019NUI Galway companies garner $40m in 2018
NUI Galway-linked businesses to have secured backing last year include kidney reflux test spinout Kite Medical and medical implant developer Loci Orthopaedics.
Jan 9, 2019Exscientia sends for $26m
Celgene and Evotec both invested in Exscientia, as the automated drug discovery services provider added Roche to its roster of development partners.
Jan 9, 2019Mitsui Fudosan pinpoints GeoSpock for more funding
Big data technology developer GeoSpock more than doubled its overall funding to $24.5m in a $12.8m round co-led by Mitsui Fudosan.
Jan 9, 2019Sanofi hands $91m to Biontech
Biontech, a spinout of Johannes Gutenberg University Mainz, has received $91.5m in funding as part of the extension of a deal to develop a cancer immunotherapy candidate with Sanofi.
Jan 8, 2019GeoSpock pinpoints $12.8m
Cambridge big data analytics spinout GeoSpock has now raised $24.5m from investors including Cambridge Innovation Capital and Parkwalk Advisors.
Jan 8, 2019Atriva finds series A relief
Spun out of Tübingen, Justus Liebig University Gießen and Münster, Atriva Therapeutics has raised an initial $1.4m to progress next-generation antiviral drugs for conditions including influenza.
Jan 8, 2019Alibaba recruits Data Artisans in $103m acquisition
Intel Capital and Tengelmann Ventures are set to exit data processing technology developer Data Artisans, having backed its $6.3m series A round.
Jan 8, 2019Sophia Genetics generates $77m
The genomic testing platform developer has now raised some $140m, eight years after being co-founded in EPFL's Innovation Park by researchers from EMBL, Stanford and Geneva University.
Jan 8, 2019Exscientia sends for $26m
Celgene and Evotec have put capital into Exscientia as the Dundee-founded automated drug discovery services provider added Roche to its roster of development partners.
Jan 8, 2019About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
Navigation
test regLogin
Not yet subscribed?
We use cookies to enhance your browsing experience and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Accept Read MorePrivacy & Cookies PolicyPrivacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.


